1. Rietschel, E., Brade, L., Schade, U., Tacken, A., Zähringer, U., Loppnow, H., Flad, H.-D., Brade, H.: Bacterial Endotoxins: Structure-activity relationships, In: (W. Marget, W. Lang, E. Gabler-Sandberger, eds.) Proceedings IXth International Congress of Infectious and Parasitic Diseases. Munich, 1986, Vol. II, pp. 36–38.
2. Glauser, M. P., Baumgartner, J. D.: Clinical experience with anticore glycolipid antibodies in the prevention and treatment of gram-negative septic shock. In: (W. Marget, W. Lang, E. Gabler-Sandberger, eds.) Proceedings IXth International Congress of Infectious and Parasitic Diseases. Munich 1986, Vol. II, pp. 56–57.
3. Marget, W., Schüßler, P., Kruis, W., Weinzierl, M., Rindfleisch, G. Is the pathogenesis of Crohn's disease similar to that of juvenile recurrent pyelonephritis? Infection 4 (1976) 2–4.
4. Mar, P. J., Marget, W., Belohradsky, B. H., Roos, R.: Assay of IgG and IgM antibody titers to lipid A in sepsis and pyelonephritis. 24th ICAAC, Washington, D. C., 1985 Abstract no. 707, p. 213.
5. Marget, W., Mar, P. J., Jaspers, L. M., Possinger, K., Haslberger, H. Preliminary study on administration of high-titer lipid A antibody serum in sepsis and septic shock patients. Infection 3 (1985) 120–124.